A cross-sectional analysis of two independent general population-based studies showed that a higher serum apoA-I level was associated with a lower prevalence of CKD, and a lower serum apoA-I level and a higher apoB/A-I ratio were associated with a lower estimated glomerular filtration rate (eGFR) [12]. This evidence concerns the gene APOA1 and chronic kidney disease.